Loading…
Evert B. Schimmelpennink is President, CEO and Secretary at Lenz Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Mar 30, 2026, each linked to the official Form 4.
President, CEO and Secretary
Disclosures on record
2
Companies involved
1
Lenz TherapeuticsLENZ
2 disclosures · Jan 2026 – Mar 2026 · 1 bought
Mar 27, 2026Bought~$251Kdisclosed Mar 30
DetailsOfficial recordJan 2, 2026358Kdisclosed Jan 6
DetailsOfficial record